gastric cancer
Showing NaN - NaN of 88
Gastric Cancer Trial in Shanghai (Oxaliplatin, Teysuno, Transarterial chemoembolization (TACE))
Not yet recruiting
- Gastric Cancer
- Oxaliplatin
- +2 more
-
Shanghai, Shanghai, ChinaZhongShan hospital FuDan university
May 25, 2022
NSCLC, Small Cell Lung Cancer, Pancreas Cancer Trial in Shanghai (Infusion of iNKT cells and CD8+T cells)
Active, not recruiting
- Non-small Cell Lung Cancer
- +5 more
- Infusion of iNKT cells and CD8+T cells
-
Shanghai, Shanghai, ChinaShanghai Public Health Clinical Center
May 6, 2022
Chemotherapy(Docetaxel, Oxaliplatin Plus S1 ) Followed With
Enrolling by invitation
- Gastric Cancer
- Gastrectomy
- +3 more
-
Shanghai, Shanghai, ChinaZhongshan hospital
May 1, 2022
NSCLC, Gastric Cancer, Hepatocellular Carcinoma Trial in Beijing, Shanghai (natural killer T cell)
Recruiting
- Non-small Cell Lung Cancer
- +3 more
- natural killer T cell
-
Beijing, China
- +1 more
Apr 26, 2022
Gastric Cancer, Gastroesophageal Junction Cancer Trial in Worldwide (BBI608, Paclitaxel, Placebo)
Completed
- Gastric Cancer
- Gastroesophageal Junction Cancer
- BBI608
- +2 more
-
Scottsdale, Arizona
- +262 more
Apr 4, 2022
Hypoxia, Gastric Cancer, Gastric Polyp Trial in Zhenzhou, Qingdao, Shanghai (Capnography monitoring, Standard monitoring)
Recruiting
- Hypoxia
- +5 more
- Capnography monitoring
- Standard monitoring
-
Zhenzhou, Henan, China
- +2 more
Mar 7, 2022
Gastric Cancer Trial in Shanghai (Apatinib)
Completed
- Gastric Cancer
-
Shanghai, Shanghai, ChinaShanghai 6th People's Hospital
Feb 24, 2022
Advanced Solid Tumor, Cholangiocarcinoma, Biliary Tract Cancer Trial in Beijing, Jinan, Shanghai (TT-00420, Combination Product:
Not yet recruiting
- Advanced Solid Tumor
- +10 more
- TT-00420
- +2 more
-
Beijing, China
- +3 more
Feb 14, 2022
Solid Tumor, Gastric Cancer, Pancreatic Adenocarcinoma Trial in China (AB011 Injection)
Recruiting
- Solid Tumor
- +2 more
- AB011 Injection
-
Hefei, Anhui, China
- +11 more
Feb 7, 2022
PDO Models and Clinical Outcomes in Gastric Cancer
Recruiting
- Gastric Cancer
- Tumor biopsy
-
Shanghai, Shanghai, ChinaZhongshan Hospital Fudan University
Jan 10, 2022
Gastric Cancer, HER2 Overexpressing Gastric Carcinoma Trial in China (RC48-ADC, Paclitaxel injection, Irinotecan Hydrochloride
Recruiting
- Gastric Cancer
- HER2 Overexpressing Gastric Carcinoma
- RC48-ADC
- +3 more
-
Beijing, Beijing, China
- +51 more
Jan 6, 2022
Breast Cancer, Gastric Cancer Trial in Shanghai (KN026)
Active, not recruiting
- Breast Cancer
- Gastric Cancer
-
Shanghai, ChinaFudan University Shanghai Cancer Hospital
Nov 16, 2021
Gastric Cancer, Metastasis Trial in Shanghai (Apatinib Mesylate, Camrelizumab)
Recruiting
- Gastric Cancer
- Metastasis
- Apatinib Mesylate
- Camrelizumab
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Oct 15, 2021
Gastric Cancer Trial in ShangHai (Epirubicin, Oxaliplatin, Capecitabine)
Completed
- Gastric Cancer
- Epirubicin
- +2 more
-
ShangHai, Shanghai, ChinaFudan University Cancer Hospital
Oct 18, 2021
Solid Tumor, Soft Tissue Sarcoma, Gastric Cancer Trial in Shanghai (CCT301-59)
Active, not recruiting
- Solid Tumor
- +4 more
- CCT301-59
-
Shanghai, Shanghai, ChinaShanghai Zhongshan Hospital
Oct 19, 2021
Hypoxia, Gastric Cancer, Esophagus Cancer Trial in Shanghai (High-flow nasal cannula oxygenation, Regular nasal cannula)
Recruiting
- Hypoxia
- +4 more
- High-flow nasal cannula oxygenation
- Regular nasal cannula
-
Shanghai, Shanghai, China, China
- +2 more
Sep 14, 2021
Safety and Feasibility of Reversible Induction Strategy
Recruiting
- Patients With Uncertain Difficult Airway
- +3 more
-
Shanghai, Shanghai, ChinaRen Ji Hospital Affliated to School of Medicine, Shanghai Jiao T
Sep 11, 2021
Gastric Cancer Trial in Shanghai (PD-1 inhibitor, Oxaliplatin, Capecitabine)
Recruiting
- Gastric Cancer
- PD-1 inhibitor
- +6 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Aug 1, 2021
Gastric Cancer, Precancerous Lesion, Helicobacter Pylori Infection Trial in China (pepsinogen)
Recruiting
- Gastric Cancer
- +2 more
- pepsinogen
-
Jilin, Jilin, China
- +8 more
Jul 25, 2021
Gastric Cancer, Neoadjuvant Chemo Trial in Shanghai (Chemotherapy)
Not yet recruiting
- Gastric Cancer
- Neoadjuvant Chemotherapy
-
Shanghai, Shanghai, ChinaRuijin Hospital Shanghai Jiaotong University School of Medicine
Jul 15, 2021
Gastric Cancer Trial in Worldwide (5-Fluorouracil, Capecitabine, Cisplatin)
Gastric Cancer, Gastro-oesophageal Junction Cancer, Immunotherapy Trial in Shanghai (Anlotinib Plus Toripalimab)
Recruiting
- Gastric Cancer
- +4 more
- Anlotinib Plus Toripalimab
-
Shanghai, ChinaDepartment of Medical Oncology, Shanghai Changzheng Hospital
Dec 28, 2020
Gastric Cancer, Cetuximab, Nimotuzumab Trial in Shanghai (EGFR antibody and Chemotherapy, Chemotherapy)
Recruiting
- Gastric Cancer
- +2 more
- EGFR antibody and Chemotherapy
- Chemotherapy
-
Shanghai, ChinaDepartment of Medical Oncology, Shanghai Changzheng Hospital
Dec 28, 2020